Literature DB >> 23355534

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.

Richard D Starke1, Koralia E Paschalaki, Clare E F Dyer, Kimberly J Harrison-Lavoie, Jacqueline A Cutler, Thomas A J McKinnon, Carolyn M Millar, Daniel F Cutler, Mike A Laffan, Anna M Randi.   

Abstract

Von Willebrand disease (VWD) is a heterogeneous bleeding disorder caused by decrease or dysfunction of von Willebrand factor (VWF). A wide range of mutations in the VWF gene have been characterized; however, their cellular consequences are still poorly understood. Here we have used a recently developed approach to study the molecular and cellular basis of VWD. We isolated blood outgrowth endothelial cells (BOECs) from peripheral blood of 4 type 1 VWD and 4 type 2 VWD patients and 9 healthy controls. We confirmed the endothelial lineage of BOECs, then measured VWF messenger RNA (mRNA) and protein levels (before and after stimulation) and VWF multimers. Decreased mRNA levels were predictive of plasma VWF levels in type 1 VWD, confirming a defect in VWF synthesis. However, BOECs from this group of patients also showed defects in processing, storage, and/or secretion of VWF. Levels of VWF mRNA and protein were normal in BOECs from 3 type 2 VWD patients, supporting the dysfunctional VWF model. However, 1 type 2M patient showed decreased VWF synthesis and storage, indicating a complex cellular defect. These results demonstrate for the first time that isolation of endothelial cells from VWD patients provides novel insight into cellular mechanisms of the disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355534      PMCID: PMC3617637          DOI: 10.1182/blood-2012-06-435727

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Origins of circulating endothelial cells and endothelial outgrowth from blood.

Authors:  Y Lin; D J Weisdorf; A Solovey; R P Hebbel
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.

Authors:  David A Ingram; Laura E Mead; Hiromi Tanaka; Virginia Meade; Amy Fenoglio; Kelly Mortell; Karen Pollok; Michael J Ferkowicz; David Gilley; Mervin C Yoder
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

3.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

4.  Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.

Authors:  B M Ewenstein; A Inbal; J S Pober; R I Handin
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

5.  Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.

Authors:  Lee A O'Brien; Paula D James; Maha Othman; Ergul Berber; Cherie Cameron; Colleen R P Notley; Carol A Hegadorn; Jeffrey J Sutherland; Christine Hough; Georges E Rivard; Denise O'Shaunessey; David Lillicrap
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

6.  Search for mutations in a segment of the exon 28 of the human von Willebrand factor gene: new mutations, R1315C and R1341W, associated with type 2M and 2B variants.

Authors:  P Casaña; F Martínez; C Espinós; S Haya; J I Lorenzo; J A Aznar
Journal:  Am J Hematol       Date:  1998-09       Impact factor: 10.047

7.  Multimeric analysis of von Willebrand factor by vertical sodium dodecyl sulphate agarose gel electrophoresis, vacuum blotting technology and sensitive visualization by alkaline phosphatase anti-alkaline phosphatase complex.

Authors:  P Baillod; B Affolter; G H Kurt; R Pflugshaupt
Journal:  Thromb Res       Date:  1992-06-15       Impact factor: 3.944

8.  Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.

Authors:  S E Lyons; M E Bruck; E J Bowie; D Ginsburg
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

9.  Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.

Authors:  A B Federici; P G de Groot; M Moia; M J Ijsseldijk; J J Sixma; P M Mannucci
Journal:  Br J Haematol       Date:  1993-01       Impact factor: 6.998

10.  The physiological function of von Willebrand's factor depends on its tubular storage in endothelial Weibel-Palade bodies.

Authors:  Grégoire Michaux; Kate B Abbitt; Lucy M Collinson; Sandra L Haberichter; Keith E Norman; Daniel F Cutler
Journal:  Dev Cell       Date:  2006-02       Impact factor: 12.270

View more
  37 in total

1.  Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.

Authors:  Ashley Cartwright; Simon J Webster; Annika de Jong; Richard J Dirven; Lisa D S Bloomer; Ahlam M Al-Buhairan; Ulrich Budde; Christer Halldén; David Habart; Jenny Goudemand; Ian R Peake; Jeroen C J Eikenboom; Anne C Goodeve; Daniel J Hampshire
Journal:  Blood Adv       Date:  2020-07-14

Review 2.  Genetic sequence analysis of inherited bleeding diseases.

Authors:  Flora Peyvandi; Tom Kunicki; David Lillicrap
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

Review 3.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

4.  Standardization of methods to quantify and culture endothelial colony-forming cells derived from peripheral blood: Position paper from the International Society on Thrombosis and Haemostasis SSC.

Authors:  David M Smadja; Juan M Melero-Martin; Jeroen Eikenboom; Mackenzie Bowman; Florence Sabatier; Anna M Randi
Journal:  J Thromb Haemost       Date:  2019-05-22       Impact factor: 5.824

5.  Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.

Authors:  Alison Michels; Laura L Swystun; Jeffrey Mewburn; Silvia Albánez; David Lillicrap
Journal:  J Vis Exp       Date:  2017-08-14       Impact factor: 1.355

6.  Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.

Authors:  Soundarya N Selvam; Lara J Casey; Mackenzie L Bowman; Lindsey G Hawke; Avery J Longmore; Jeffrey Mewburn; Mark L Ormiston; Stephen L Archer; Donald H Maurice; Paula James
Journal:  Blood Coagul Fibrinolysis       Date:  2017-10       Impact factor: 1.276

Review 7.  von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.

Authors:  David Lillicrap
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113

8.  Significant gynecological bleeding in women with low von Willebrand factor levels.

Authors:  Michelle Lavin; Sonia Aguila; Niall Dalton; Margaret Nolan; Mary Byrne; Kevin Ryan; Barry White; Niamh M O'Connell; Jamie M O'Sullivan; Jorge Di Paola; Paula D James; James S O'Donnell
Journal:  Blood Adv       Date:  2018-07-24

Review 9.  Genetic regulation of plasma von Willebrand factor levels in health and disease.

Authors:  L L Swystun; D Lillicrap
Journal:  J Thromb Haemost       Date:  2018-10-30       Impact factor: 5.824

Review 10.  von Willebrand factor regulation of blood vessel formation.

Authors:  Anna M Randi; Koval E Smith; Giancarlo Castaman
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.